Patient decision to initiate therapy for osteoporosis: The influence of knowledge and beliefs

Journal of General Internal Medicine

Volumn 23, Issue 11, 2008, Pages 1815-1821

  Yood, Robert A ^a,b   Mazor, Kathleen M ^b   Andrade, Susan E ^b   Emani, Srinivas ^a   Chan, Wing ^c   Kahler, Kristijan H ^c  

^a Fallon Clinic   (United States)

^b UNIVERSITY OF MASSACHUSETTS MEDICAL SCHOOL   (United States)

^c NOVARTIS PHARMA AG   (Switzerland)

Author keywords

Decision making; Medication adherence; Osteoporosis; Patient preferences

Indexed keywords

BISPHOSPHONIC ACID DERIVATIVE; CALCITONIN; ESTROGEN; PARATHYROID HORMONE[1-34]; RALOXIFENE;

ADULT; AGED; ARTICLE; BELIEF; BIVARIATE ANALYSIS; BONE DENSITY; DOCTOR PATIENT RELATION; DRUG USE; DUAL ENERGY X RAY ABSORPTIOMETRY; ELECTRONIC MEDICAL RECORD; FEMALE; HEALTH CARE UTILIZATION; HEALTH SURVEY; HUMAN; KNOWLEDGE; MANAGED CARE; MEDICAL RESEARCH; OSTEOPOROSIS; PATIENT DECISION MAKING; PERCEPTION; PHYSICIAN; PRESCRIPTION; QUESTIONNAIRE; SATISFACTION; WORLD HEALTH ORGANIZATION;

ADULT; AGED; BONE DENSITY CONSERVATION AGENTS; COHORT STUDIES; FEMALE; HEALTH KNOWLEDGE, ATTITUDES, PRACTICE; HEALTH SURVEYS; HUMANS; MANAGED CARE PROGRAMS; MEDICATION ADHERENCE; MIDDLE AGED; OSTEOPOROSIS; PATIENT SATISFACTION;

EID: 56749163410     PISSN: 08848734     EISSN: 15251497     Source Type: Journal    
DOI: 10.1007/s11606-008-0772-0     Document Type: Article

References (37)

1. National Committee for Quality Assurance. Medicare HEDIS 2006 means, percentiles and ratios. http://www.ncqa.org/tabid/494/Default.aspx. Accessed August 15, 2008.
2. JS McCombs P Thiebaud C McLaughlin-Miley J Shi 2004 Compliance with drug therapies for the treatment and prevention of osteoporosis Maturitas 48 271 287
3. AN Tosteson MR Grove CS Hammond MM Moncur GT Ray GM Hebert AR Pressman B Ettinger 2003 Early discontinuation of treatment for osteoporosis Am J Med 115 209 216
4. A Papaioannou CC Kennedy L Dolovich E Lau JD Adachi 2007 Patient adherence to osteoporosis medications; problems, consequences and management strategies Drugs Aging 24 37 55
5. DH Solomon J Avorn JN Katz JS Finkelstein M Arnold JM Polinski MA Brookhart 2005 Compliance with osteoporosis medications Arch Intern Med 165 2414 2419
6. ES Siris ST Harris CJ Rosen CE Barr JN Arvesen TA Abbott S Silverman 2006 Adherence to bisphosphonate therapy and fracture rates in osteoporotic women: relationship to vertebral and nonvertebral fractures from 2 US claims databases Mayo Clin Proc 81 1013 1022
7. JJ Caro KJ Ishak KF Huybrechts G Raggio C Naujoks 2004 The impact of compliance with osteoporosis therapy on fracture rates in actual practice Osteoporos Int 15 1003 1008
8. KF Huybrechts KJ Ishak JJ Caro 2006 Assessment of compliance with osteoporosis treatment and its consequences in a managed care population Bone 38 922 928
9. BA Briesacher SE Andrade RA Yood KH Kahler 2007 Consequences of poor compliance with bisphosphonates Bone 41 882 887
10. RB Haynes KA McKibbon R Kanani 1996 Systematic review of randomized trials of interventions to assist patients to follow prescriptions for medications Lancet 348 383 386
11. PA Heidenreich 2004 Patient adherence: the next frontier in quality improvement Am J Med 117 130 132
12. AM Peterson L Takiya R Finley 2003 Meta-analysis of trials of interventions to improve medication adherence Am J Health Syst Pharm 60 657 665
13. E Vermeire H Hearnshaw P Van Royen J Denekens 2001 Patient adherence to treatment: three decades of research. A comprehensive review J Clin Pharm Ther 26 331 342
14. L Osterberg T Blaschke 2005 Adherence to medication N Engl J Med 353 487 497
15. MA Brookhart J Avorn JN Katz JS Finkelstein M Arnold JM Polinski AR Patrick H Mogun DH Solomon 2007 Gaps in treatment among users of osteoporosis medications: The dynamics of noncompliance Am J Med 120 251 256
16. RA Yood S Emani JI Reed BE Lewis M Charpentier E Lydick 2003 Compliance with pharmacologic therapy for osteoporosis Osteoporos Int 14 965 968
17. E Badamgarav LA Fitzpatrick 2006 A new look at osteoporosis outcomes: The influence of treatment, compliance, persistence, and adherence Mayo Clin Proc 81 1009 1012
18. CG Unson E Siccion J Gaztambide S Gaztambide P Mahoney Trella K Prestwood 2003 Nonadherence and osteoporosis treatment preferences of older women: a qualitative study J Womens Health (Larchmt) 12 1037 1045
19. TW Weiss DT Gold SL Silverman CA McHorney 2006 An evaluation of patient preferences for osteoporosis medication attributes: Results form the PREFER US Study Curr Med Res Opin 22 949 960
20. MJ Johnson 2002 The medication adherence model: a guide for assessing medication taking Res Theory Nurse Pract 16 179 192
21. J Dowell H Hudson 1997 A qualitative study of medication-taking behaviour in primary care Fam Prac 14 369 375
22. J Benson N Britten 2002 Patients' decisions about whether or not to take antihypertensive drugs: Qualitative study BMJ 325 873
23. P Pound N Britten M Morgan L Yardley C Pope G Daker-White R Campbell 2005 Resisting medicines: A synthesis of qualitative studies on medicine taking Soc Sci Med 61 133 155
24. S Svensson KI Kjellgren J Ahlner R Saljo 2000 Reasons for adherence with antihypertensive medication Int J Cardiol 76 157 163
25. MR DiMatteo KB Haskard SL Williams 2007 Health beliefs, disease severity, and patient adherence. A meta-analysis Med Care 45 521 528
26. RR Cline JF Farley RA Hansen JC Schommer 2005 Osteoporosis beliefs and antiresorptive medication use Maturitas 50 196 208
27. ME Charlson P Pompei KL Ales CR MacKenzie 1987 A new method of classifying prognostic comorbidity in longitudinal studies; Development and validation J Chronic Dis 40 373 383
28. RA Deyo DC Cherkin MA Ciol 1992 Adapting a clinical comorbidity index for use with ICD-9-CM administrative databases J Clin Epidemiol 45 613 619
29. American Board of Internal Medicine. Final report on the patient satisfaction questionnaire project. Washington DC. 1989.
30. E Dugan F Trachtenberg MA Hall 2005 Development of abbreviated measures to assess patient trust in a physician, a health insurer, and the medical profession BMC Health Serv Res 5 64
31. P Werner 2005 Knowledge about osteoporosis: Assessment, correlates and outcomes Osteoporos Int 16 115 127
32. KM Mazor MA Fischer S Billings-Gagliardi 2008 Initial acceptance of treatment with antihypertensive medication: the importance of communication, trust and beliefs J Commun Healthcare 1 311 323
33. MA Brookhart AR Patrick S Schneeweiss J Avorn C Dormuth W Shrank BL van Wijk SM Cadarette CF Canning DH Solomon 2007 Physician follow-up and provider continuity are associated with long-term medication adherence: a study of the dynamics of statin use Arch Intern Med 167 847 852
34. MA Brookhart AR Patrick C Dormuth J Avorn W Shrank SM Cadarette DH Solomon 2007 Adherence to lipid-lowering therapy and the use of preventive health services: An investigation of the healthy user effect Am J Epidemiol 166 348 354
35. M Rossini G Bianchi O Di Munno S Giannini S Minisola L Sinigaglia S Adami 2006 Treatment of osteoporosis in clinical practice (TOP) study group. Determinants of adherence to osteoporosis in clinical practice Osteoporos Int 17 914 921
36. E Segal A Tamir S Ish-Shalom 2003 Compliance of osteoporotic patients with different treatment regimens Isr Med Assoc J 5 859 862
37. L Fraenkel B Gulanski D Wittink 2006 Patient treatment preferences for osteoporosis Arthritis Rheum 55 729 735